Montrium Releases Regulatory Navigator
The Regulatory Navigator is an Integrated Regulatory Information Management Tool for RegDocs Connect
Montreal, QC - Montrium, regulatory compliance specialists, and enterprise content management software providers, today, announced the commercial release of the Regulatory Navigator, an interactive intelligence dashboard integrated into RegDocs Connect, their Regulatory EDMS. Equipped with powerful business intelligence and intuitive regulatory document management, pharmaceutical organizations now have the tools to significantly improve the quality of their content while speeding up the submission timeline.
As the FDA deadline for eCTD submissions approaches and the complexity of drug development continues to increase, life sciences companies need sophisticated and easy to use tools that help them produce submission-ready, quality content in a timely manner. By combining document creation, dossier management, product registrations, and health authority interactions in one place, life sciences companies can increase the speed, efficiency, agility and compliance of their regulatory teams.
"Traditionally, Life Sciences companies have struggled with disconnected regulatory landscape, where information is managed in several systems, and in multiple regions," said Paul Fenton, President & CEO at Montrium. "The Regulatory Navigator, paired with RegDocs Connect marries essential RIM functionality with powerful document authoring and management, allowing regulatory teams to create, plan and track the entire regulatory timeline, in one place."
Much like Montrium's other Navigator tools, the Regulatory Navigator provides visual indicators that provide clarity and transparency over the completeness of your submissions, ensuring that everything you send for publishing is submission-ready. Regulatory teams can now quickly identify all available, expected, in-process or missing submission documents by products, regions, countries, applications or sequences and begin creating regulatory activities directly in the navigator.
The Regulatory Navigator is now available globally as part of Montrium's RegDocs Connect product. To learn more about Navigator Tools or to schedule a demo of the Regulatory Navigator, please register for our live demonstration where we will be giving attendees an exclusive walkthrough of the Regulatory Navigator.
Additional Information
- To learn more about the Montrium Connect platform and it's suite of regulated content management applications, including RegDocs connect & eTMF Connect, visit www.montrium.com/connect
- To learn more about Montrium's latest release, please visit: http://www.montrium.com/regdocs-connect/navigator
- Stay up to date on the latest Montrium news on LinkedIn: www.linkedin.com/company/montrium
About Montrium
Montrium is a global leader in cloud-based document & quality management solutions (QMS) and GxP consulting services for the Life Sciences. Operating in the Life Sciences for over ten years, Montrium has been successfully helping organizations implement and maintain technology to improve their business processes and increase compliance. Montrium currently serves over 7500 satisfied users in over 20 countries. For more information on the products and services Montrium provides, please visit their website: www.montrium.com
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025In this episode, we meet with Micah Lieberman, Executive Conference Director for SCOPE Summit (Summit for Clinical Ops Executives) at Cambridge Innovation Institute. We will dive deep into the critical role of collaboration within the clinical research ecosystem. How do we bring together diverse stakeholders—sponsors, CROs, clinical trial tech innovators, suppliers, patients, sites, advocacy organizations, investors, and non-profits—to share best practices in trial design, program planning, innovation, and clinical operations? We’ll explore why it’s vital for thought leaders to step beyond their own organizations and learn from others, exchanging ideas that drive advancements in clinical research. Additionally, we’ll discuss the pivotal role of scientific conferences like SCOPE Summit in fostering these essential connections and collaborations, helping shape the future of clinical trials. Join us as we uncover how collective wisdom and cross-industry partnerships are transforming the landscape of clinical research.
Landmark Phase III Trial Shows Keytruda Significantly Improves Event-Free Survival in LA-HNSCC
April 28th 2025Interim KEYNOTE-689 trial data show that perioperative Keytruda significantly lowers the risk of disease progression or recurrence in resectable, locally advanced head and neck squamous cell carcinoma, marking the first major clinical advance for this patient population in more than two decades.
